HaroldCStandifordMD
Infectious Disease • Baltimore, MDClinical Professor, Internal Medicine, University of Maryland School of Medicine
Are you Dr. Standiford?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-5793Fax+1 410-328-0248
Summary
- Dr. Harold Standiford, MD is an infectious disease specialist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is affiliated with Veterans Affairs Maryland Health Care System-Baltimore Division and University of Maryland Medical Center.
Education & Training
University of WashingtonFellowship, Infectious Disease, 1967 - 1969- University of WashingtonResidency, Internal Medicine, 1966 - 1967
University of MarylandResidency, Internal Medicine, 1965 - 1966
University of Maryland Medical Center Midtown CampusInternship, Transitional Year, 1964 - 1965
University of Maryland School of MedicineClass of 1964
Certifications & Licensure
MD State Medical License 1972 - 2017
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3
- Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)
- A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsEffectiveness of an antimicrobial polymer to decrease contamination of environmental surfaces in the clinical setting.Kerri A. Thom, Harold C. Standiford, J. Kristie Johnson, Nader Hanna, Jon P. Furuno
Infection Control and Hospital Epidemiology. 2014-06-20 - 158 citationsAntimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program.Harold C. Standiford, Shannon Chan, Megan Tripoli, Elizabeth Weekes, Graeme N. Forrest
Infection Control and Hospital Epidemiology. 2012-03-14 - 5 citationsEmpiric antimicrobial therapy for Gram-negative sepsis: back to the futureSurbhi Leekha, Harold C. Standiford
Critical Care Medicine. 2011-08-01
